Information was received from a consumer regarding a patient who was implanted with a neurostimulator (ins) for urinary dysfunction/sacral nerve stim and gastrointestinal/pelvic floor.It was reported that the patient¿s stimulator seemed to be working for the past 3 months but now she noticed she was having issues after getting back from vacation.The patient clarified that she was referring to having a loss of therapy/return of symptoms.The patient stated that she had to turn her stimulator on and off multiple times due to the airport security and wondered if the change in therapy was related to turning the stimulator on and off so often.The patient stated that she noticed when she turned the stimulation back on, that it "almost hurt" and it seemed too strong.The patient reported that she tried decreasing the stimulation, which did not resolve the issue but then tried changing the program, which did resolve the uncomfortable stimulation.The patient reported that since implant, she has noticed she continues to have a problem with liquids.The patient noted that she had the stimulator implanted for incontinence, and that most of her "every day" was fine (typically gets 50% symptom control) and no longer wears depends.However, she has trouble with her symptom control when she consumes liquids, especially alcohol.When the patient was asked if the symptoms were sudden or gradual, the patient replied that she did not know.The patient reported that the healthcare provider (hcp) prescribed her something to help relax her bladder as well.The patient noted that the prescription began after her implanted stimulator.The patient stated that she changed to p2, and that she has tried all 4 programs available on her patient programmer (pp) and they seem "okay", but the patient inquired if other programs can be added.Patient services reviewed programming considerations.Patient services reviewed that it takes time for the body to respond to therapy, therefore titrations should be discussed with their healthcare provider (hcp).The patient was redirected to follow up with their hcp to discuss symptoms and programming.No further complications were anticipated/reported.
|